DipCatcherDipCatcher by KAWUMS
Market
AAL.L3,913.00 p+1.3%AAPL$332.41+0.3%ACN$189.64-1.9%ADA$0.1960+0.3%ADBE$250.50-2.8%ADS.DE€144.70+2.0%AIR.DE€196.74+0.9%ALGO$0.0896+0.9%ALV.DE€449.20+1.0%AMD$512.50+1.6%AMZN$245.96-1.0%ANTO.L3,594.00 p+2.7%ATOM$1.52+0.2%AUTO.L499.60 p+0.9%AV.L714.60 p+0.4%AVAX$7.53+3.5%AVGO$339.51+0.1%AXP$312.43-3.7%AZN.L12,136.00 p+0.2%BA.L2,029.00 p+1.1%BAC$57.90-2.7%BARC.L475.43 p+1.1%BAS.DE€52.13+0.6%BATS.L4,196.00 p-0.6%BAYN.DE€48.98+0.6%BCH$220.51+1.6%BEI.DE€74.68+0.2%BMW.DE€62.40-0.7%BNB$723.61+1.6%BNZL.L2,596.00 p+0.2%BP.L565.75 p-2.5%BRK-B$519.80+0.6%BT-A.L205.80 p+1.0%BTC$76,267.52+0.9%C$132.95-2.4%CAT$782.72-0.1%CBK.DE€41.61-2.0%CCH.L4,604.00 p-0.0%CON.DE€69.86+1.9%COST$893.74-0.8%CPG.L31.09 p-1.0%CRDA.L3,148.00 p-0.2%CRM$250.54-2.0%CSCO$107.74-2.1%CVX$211.54-2.9%DB1.DE€277.60+0.1%DBK.DE€33.63+0.9%DGE.L1,620.25 p+0.7%DHER.DE€36.70-0.1%DHL.DE€55.76-0.1%DIS$106.99+0.5%DOGE$0.0809+1.0%DOT$1.01+7.0%DTE.DE€28.84-0.2%ENT.L499.80 p+0.3%EOAN.DE€17.60+1.2%ETC$7.40+2.9%ETH$2,433.29+1.4%EVT.DE€2.81+0.1%EXPN.L2,784.00 p-0.6%FME.DE€39.86+0.2%FRE.DE€46.06+1.5%G24.DE€75.00+0.5%GFT.DE€26.25-1.1%GLEN.L570.90 p-0.9%GOOGL$342.87-0.6%GS$937.98-4.0%GSK.L1,865.50 p+0.6%GXI.DE€27.66-0.5%HD$302.47-1.0%HEI.DE€150.90+1.2%HEN3.DE€73.80+1.3%HNR1.DE€255.80+0.2%HON$207.66+2.1%HSBA.L1,511.50 p+0.5%IBM$237.49-4.4%IFX.DE€55.00+1.2%III.L2,668.00 p+2.7%IMB.L2,490.00 p-1.0%INTC$101.05+4.0%JMAT.L2,286.00 p+0.4%JNJ$267.28+0.0%JPM$348.92-1.0%KGX.DE€41.61+0.5%LAND.L636.00 p+1.8%LGEN.L300.75 p+2.2%LHA.DE€7.63+1.1%LINK$11.10+1.9%LLOY.L111.25 p+2.2%LLY$1,137.82+0.2%LOW$194.10-0.3%LSEG.L8,150.00 p-0.6%LTC$51.98+1.4%LXS.DE€13.52-0.9%MA$567.75-1.0%MBG.DE€45.50-2.3%MDT$92.60-1.2%META$673.31+0.5%MNG.L335.40 p+0.6%MS$202.42-1.9%MSFT$490.30-1.4%MTX.DE€339.40+1.8%MUV2.DE€511.60-0.2%NDA.DE€164.60+0.5%NDX1.DE€39.18+1.2%NEE$80.37-0.9%NFLX$76.41-1.9%NG.L1,136.00 p+2.3%NOW$139.82-1.5%NVDA$213.90+0.8%OCDO.L212.60 p+2.8%ORCL$143.16+2.0%PAH3.DE€28.73-1.8%PEP$134.34-0.9%PG$147.02+0.2%PM$191.71-1.2%PRU.L979.50 p+0.6%PSN.L1,163.00 p+5.9%PUM.DE€22.36+2.5%QCOM$184.84-1.6%QIA.DE€37.27+0.2%REL.L2,530.00 p-0.2%RIO.L7,202.00 p+0.8%RKT.L5,064.00 p-0.0%RMV.L501.40 p+0.7%RR.L1,440.60 p+1.4%RWE.DE€59.90+2.8%SAP.DE€186.20-0.5%SAX.DE€36.56-0.3%SBRY.L334.50 p-0.7%SBUX$97.34+0.8%SDF.DE€16.71+1.6%SGE.L1,011.50 p+0.4%SGRO.L942.00 p+0.7%SHEL.L3,577.00 p-2.1%SHIB$0.0000-0.2%SHL.DE€38.36-1.3%SIE.DE€260.50+0.7%SOL$99.42+2.6%SSE.L2,405.00 p+3.1%STAN.L2,287.00 p+0.9%SY1.DE€91.46+2.3%T$25.86-3.2%TKA.DE€15.44+1.9%TRX$0.3355+0.8%TSCO.L476.20 p-0.7%TSLA$358.08+0.4%TXN$260.67-1.0%ULVR.L4,640.00 p-0.0%UNH$375.26-0.2%UNP$280.92-1.1%UPS$98.77-3.5%V$370.93-1.2%VNA.DE€17.89-0.7%VOD.L130.92 p-0.2%VOW3.DE€79.20-2.2%WEIR.L2,634.00 p+1.4%WMT$107.50-0.5%WPP.L381.20 p-0.8%XLM$0.1824+3.5%XOM$163.32-3.5%XRP$1.30+0.9%ZAL.DE€21.48-1.2%
Dips
HON-17.1%Buy VNA.DE-16.9%Buy OCDO.L-22.3%Watch FME.DE-7.8%Watch BA.L-12.1%Watch ADS.DE-15.5%Watch AUTO.L-10.6%Watch G24.DE-8.6%Watch GOOGL-10.8%Watch LLY-12.0%Watch

EVT.DE

XETRA

Evotec SE

Healthcare · Drug Manufacturers - Specialty & Generic

€2.81
+0.1% today · 13 h ago

Price

-38.1% · 3 months
1m3m6m
€3.39€3.98€4.5818/06/202631/07/202616/09/2026
High €5.15 · 06/07/2026Low €2.81 · 15/09/2026

Why is it down?

no visible trigger
  • ·From its high of €3.85 on 12/08/2026 the price fell 27.7% to €2.81.
  • ·The biggest single-day drop was 7.8% on 13/08/2026.
  • ·No clear news driver in the last 10 days.
  • ·The market as a whole is calm, so this drop is specific to the company.
  • ·Other Drug Manufacturers - Specialty & Generic stocks we track are down only 6.1% on average, so this is mostly about the company. See all 13 in this sector →

A drop without a visible trigger is often selling pressure, not new facts. That is the kind of dip the engine looks for, but it is still a guess, not a promise.

Verdict

signal 56 min ago
WATCH-27.7% below 30-day high

A dip is in progress: 27.7% below its 30-day high, but the fall has not shown a bottom yet. Wait; the verdict turns to Buy when at least 3 of 5 bottom checks pass.

Sign in to watch

Catalysts

1 h ago
News, last 10 days
no recent news
Next earnings
05/11/2026 · in 49 days
Last report
05/11/2025 -81.1% vs estimate

Trade levels

Free account · 3 tickers a day

Why the engine says so

Free account · 3 tickers a day

History for this ticker

Free account · 3 tickers a day

Watch and alert

Free account · 3 tickers a day

About Evotec SE

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just – Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic disease, and rare diseases; central nervous system (CNS) and cardiometabolic diseases; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. It has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN², Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB. The company serves pharma and biotechnology companies, academic institutions, patient advocacy groups, and venture capital. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Headquarters:
Hamburg, Germany
52-week range:
€2.77 – €7.30
Website:
evotec.com

Signals are generated automatically from price, volume and technical indicators. They are not investment advice.← Back to search